Celcuity, Inc. (CELC)
60.46
-3.91
(-6.07%)
USD |
NASDAQ |
Nov 16, 16:00
60.46
0.00 (0.00%)
After-Hours: 18:50
Celcuity Shareholders Equity (Quarterly) : -74.04M for Sept. 30, 2026
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2026 | -74.04M |
| June 30, 2026 | -12.78M |
| March 31, 2026 | 53.52M |
| December 31, 2025 | 100.56M |
| September 30, 2025 | 116.96M |
| June 30, 2025 | 44.38M |
| March 31, 2025 | 86.67M |
| December 31, 2024 | 115.62M |
| September 30, 2024 | 149.71M |
| June 30, 2024 | 176.68M |
| March 31, 2024 | 133.74M |
| December 31, 2023 | 139.77M |
| September 30, 2023 | 92.90M |
| June 30, 2023 | 110.13M |
| March 31, 2023 | 123.23M |
| December 31, 2022 | 133.77M |
| September 30, 2022 | 43.53M |
| June 30, 2022 | 53.19M |
| March 31, 2022 | 61.54M |
| December 31, 2021 | 68.71M |
| Date | Value |
|---|---|
| September 30, 2021 | 74.47M |
| June 30, 2021 | 27.03M |
| March 31, 2021 | 35.17M |
| December 31, 2020 | 11.70M |
| September 30, 2020 | 13.76M |
| June 30, 2020 | 15.86M |
| March 31, 2020 | 17.52M |
| December 31, 2019 | 19.30M |
| September 30, 2019 | 20.71M |
| June 30, 2019 | 22.39M |
| March 31, 2019 | 23.86M |
| December 31, 2018 | 25.35M |
| September 30, 2018 | 26.91M |
| June 30, 2018 | 28.48M |
| March 31, 2018 | 29.94M |
| December 31, 2017 | 31.39M |
| September 30, 2017 | 32.81M |
| June 30, 2017 | 4.335M |
| March 31, 2017 | 4.720M |
Shareholders' Equity Definition
Represents the value of Shareholders' Equity as of the close of the report date, belonging to both Preferred and Common Equity Shareholders.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Beam Therapeutics, Inc. | 952.67M |
| Vera Therapeutics, Inc. | 333.19M |
| Tango Therapeutics, Inc. | 980.17M |
| Sarepta Therapeutics, Inc. | 1.529B |
| Allogene Therapeutics, Inc. | 392.55M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 726.87M |
| Total Liabilities (Quarterly) | 800.91M |
| Debt to Equity Ratio | -10.20 |
| Current Ratio | 14.62 |
| Net Debt Paydown Yield | -3.36% |